Diabetes and Your Eyes: Understanding Diabetic Retinopathy Before It’s Too Late
India is now the diabetes capital of the world — with over 80 million people living with the condition, and millions more who do not yet know they have it. In my OPD at Haripriya Eye Care Centre in Meerut, I see diabetic patients referred from across western Uttar Pradesh — from Ghaziabad, Muzaffarnagar, Hapur, Shamli, and beyond. And I have one message for every diabetic patient, delivered with the utmost seriousness: your blood sugar does not just damage your kidneys, nerves, and heart. It is silently attacking the back of your eyes — right now — often without a single symptom. Understanding diabetic retinopathy may be the single most important thing you can do to protect your vision.
How Diabetes Damages the Eyes
The retina — the thin, light-sensitive layer lining the inside back of the eye — is one of the most metabolically active and blood-supply-dependent tissues in the human body. It is laced with a dense network of tiny blood vessels (capillaries) that deliver oxygen and nutrients to the photoreceptors and supporting cells that convert light into the signals your brain interprets as vision.
Chronically elevated blood glucose damages these capillary walls in multiple ways. The vessel walls thicken and become leaky, losing their ability to selectively control what passes in and out. Proteins and lipids leak into the surrounding retinal tissue, causing swelling. The pericytes — cells that provide structural support to capillary walls — die off, weakening the vessels further. Some capillaries close off entirely, cutting off blood supply to patches of the retina. In response to this ischaemia (lack of oxygen), the retina releases a signalling molecule called Vascular Endothelial Growth Factor (VEGF), which stimulates the growth of new, fragile blood vessels — but these new vessels are poorly formed, prone to bleeding, and can cause catastrophic complications.
Approximately 30 percent of people with diabetes will develop some degree of diabetic retinopathy over the course of their illness. The risk rises dramatically with the duration of diabetes — after 20 years of diabetes, nearly all Type 1 diabetics and over 60 percent of Type 2 diabetics have some retinopathy. Poor blood sugar control, high blood pressure, anaemia, and kidney disease accelerate the process significantly.
The Four Stages of Diabetic Retinopathy
Diabetic retinopathy is classified into stages, and the stage determines both the urgency and type of treatment required:
- Mild Non-Proliferative Diabetic Retinopathy (NPDR): The earliest stage. Tiny balloon-like swellings called microaneurysms appear in the retinal capillaries. These are the first visible signs of vascular damage. There is no vision loss at this stage, and no treatment to the eye is needed — but blood sugar control is paramount, and follow-up every 12 months is essential.
- Moderate NPDR: More capillaries are damaged and partially blocked. Dot and blot haemorrhages — small spots of blood leaked from weakened vessels — appear across the retina. Hard exudates (lipid deposits) and soft exudates (cotton wool spots from nerve fibre infarcts) become visible. Retinal blood flow is increasingly compromised. Annual monitoring is no longer sufficient; follow-up should occur every 6 months.
- Severe NPDR: Defined by the "4-2-1 rule": more than 20 haemorrhages in each of four retinal quadrants, venous beading in two or more quadrants, and intraretinal microvascular abnormalities (IRMA) in one or more quadrants. Large areas of retina are being starved of blood. The risk of progressing to the next, vision-threatening stage within one year is approximately 15 percent — and significantly higher in patients with poor metabolic control. This stage requires close follow-up every 3 months and often active intervention.
- Proliferative Diabetic Retinopathy (PDR): The most advanced and dangerous stage. In response to widespread retinal ischaemia, VEGF drives the growth of fragile new vessels (neovascularisation) on the disc (NVD — neovascularisation of the disc) or elsewhere on the retina (NVE). These vessels bleed easily — a sudden large vitreous haemorrhage can cause a patient to go from normal vision to near-blindness almost overnight. The fibrous scar tissue that accompanies new vessel growth can contract and pull the retina off its underlying layer — a traction retinal detachment — which, if it involves the central macula, results in profound, often permanent vision loss.
Diabetic Macular Edema: The Most Common Cause of Vision Loss
Diabetic Macular Edema (DME) deserves special mention because it is the most common cause of vision impairment in diabetic patients — and crucially, it can occur at any stage of retinopathy, even before severe NPDR or PDR develops. The macula is the central zone of the retina responsible for sharp, detailed central vision — reading, recognising faces, driving. When leaking capillaries cause fluid to accumulate within the layers of the macula, the retinal architecture is disrupted, and central vision becomes blurred, distorted, or washed out.
DME is insidious because many patients describe it as simply needing a stronger glasses prescription. By the time the blurring is noticeable, significant macular thickening may already be present. OCT scanning — a non-invasive scan of the macula — is the gold standard for detecting and quantifying DME, often showing fluid accumulation long before it is visible to the patient.
Symptoms: Why Early Stages Are Silent
This is the most dangerous aspect of diabetic retinopathy: in the mild and moderate NPDR stages, most patients have absolutely no symptoms. The changes are confined to parts of the retina outside the central vision zone. Only when the disease advances to involve the macula (causing blurred or distorted central vision), or when a vitreous haemorrhage occurs (causing sudden floaters, shadows, or blackout of vision), do patients typically notice something is wrong — and by then, the disease is already advanced.
Symptoms that should prompt immediate evaluation include: sudden blurring of vision, new floaters or webs in vision, distorted or wavy appearance of straight lines, dark spots or shadows in the centre of vision, or a sudden curtain-like loss of part of the visual field. Do not wait to see if these improve on their own — call us immediately.
How We Diagnose Diabetic Retinopathy
A comprehensive diabetic eye evaluation at Haripriya Eye Care Centre includes:
- Dilated fundus examination: Essential and irreplaceable. After dilating the pupils with drops, I examine the retina directly with a slit lamp and lenses, assessing for haemorrhages, exudates, new vessel formation, and disc changes.
- Optical Coherence Tomography (OCT): A non-invasive, cross-sectional scan of the retina that reveals the presence, location, and severity of macular edema with extraordinary precision. It is the single most important tool for DME diagnosis and treatment monitoring.
- Fundus Fluorescein Angiography (FFA): A dye-based imaging technique in which a fluorescent dye is injected intravenously and photographs are taken as it passes through the retinal vessels. FFA maps areas of leakage, non-perfusion, and new vessel growth precisely — invaluable for planning laser treatment and identifying high-risk features.
Treatment Options: From Laser to Injections to Surgery
Laser Photocoagulation
Laser treatment remains the backbone of diabetic retinopathy management. Pan-Retinal Photocoagulation (PRP) — also called scatter laser — is used for PDR. Multiple laser burns are applied across the peripheral retina, destroying ischaemic tissue and thereby reducing the VEGF signal that drives new vessel growth. This does not restore lost vision, but it powerfully reduces the risk of severe vision loss — clinical trials demonstrated a 50 to 60 percent reduction in the risk of severe visual loss with timely PRP. Focal and grid laser is used for DME affecting or threatening the centre of the macula, sealing leaking microaneurysms and reducing macular thickening.
Anti-VEGF Injections
Intravitreal anti-VEGF injections have revolutionised the treatment of DME and PDR over the past decade. Agents including bevacizumab (Avastin), ranibizumab (Accentrix/Razumab), and aflibercept (Eylea) are injected directly into the vitreous cavity of the eye under sterile conditions, using a very fine needle. They work by blocking VEGF, thereby reducing new vessel growth, suppressing leakage, and in many cases actually improving vision in DME — something laser alone cannot reliably achieve. Multiple injections over months to years are typically required. The procedure takes only a few minutes and is performed as an outpatient under topical anaesthesia.
Vitrectomy Surgery
In advanced PDR complicated by dense vitreous haemorrhage that does not clear spontaneously, or by traction retinal detachment involving the macula, surgical vitrectomy is required. This microsurgical procedure removes the blood-filled vitreous gel, cuts the fibrovascular membranes pulling on the retina, and often includes intraoperative laser to treat the underlying retinopathy. Results are best when surgery is performed before the traction has caused prolonged macular detachment.
Prevention: The Most Powerful Tool of All
The most effective treatment for diabetic retinopathy is preventing it from developing or progressing in the first place. The evidence is unambiguous:
- Tight glucose control — maintaining HbA1c below 7 percent reduces the risk of developing retinopathy by 76 percent and slows progression in those who already have it. Every point improvement in HbA1c matters.
- Blood pressure control — maintaining BP below 130/80 mmHg independently reduces the risk of retinopathy progression. Hypertension and diabetes together are a particularly dangerous combination for the retinal vessels.
- Annual dilated eye examination — every person with diabetes, regardless of how "well controlled" they believe their sugar to be, should have a dilated retinal examination once a year. Twice yearly if retinopathy is already present. This single intervention, done consistently, has the potential to prevent most cases of diabetes-related blindness.
- Lipid control, smoking cessation, kidney protection, and regular medical review with your diabetologist all contribute to slowing retinal vascular damage.
At Haripriya, our unique advantage is that diabetic patients can see both Dr. Hari Om Tyagi for their cardiovascular risk management and me for their annual retinal evaluation — under one roof, with shared records and coordinated care. Diabetes is a systemic disease, and it deserves a systemic approach.
Frequently Asked Questions
How often should a diabetic get an eye check-up?
Every person with Type 2 diabetes should have a dilated fundus examination at the time of diagnosis, since many Type 2 diabetics have had elevated blood sugar for years before diagnosis and may already have early retinopathy. After that, annually if there is no retinopathy, and every 6 months or more frequently if retinopathy is present. For Type 1 diabetes, annual screening should begin 5 years after diagnosis. Pregnant diabetic women need examination in each trimester, as pregnancy can accelerate retinopathy dramatically. Please do not skip your annual eye appointment even if your vision seems perfectly fine — the whole point of screening is to catch disease before symptoms appear.
Can diabetic retinopathy be reversed?
In the very early stages — mild NPDR — aggressive blood sugar and blood pressure control can allow some degree of stabilisation and even mild improvement in the retinal changes. However, once significant damage has occurred — haemorrhages, exudates, new vessels, macular scarring — the structural changes cannot be fully reversed. What treatment achieves is prevention of further loss. This is why the word "prevention" is used so often in diabetic eye care: we are always racing against the disease, trying to intervene before each stage causes permanent harm. The earlier the intervention, the more vision we can protect.
I have diabetes but my vision is fine — do I still need an eye exam?
Yes, absolutely — and this is the most important message in this entire article. Good vision does not mean a healthy retina. Diabetic retinopathy in its early and moderate stages causes no visual symptoms whatsoever. The retinal damage is occurring silently, in the peripheral retina and sometimes even in the macula in its earliest form. Many patients I see have moderate or even severe NPDR with perfectly preserved 6/6 vision — but they are on the edge of a cliff. Annual dilated examination is the only way to know what is truly happening at the back of your eye.
What is the difference between diabetic retinopathy and diabetic macular edema?
Diabetic retinopathy is the umbrella term for all the damage diabetes causes to the retinal blood vessels — haemorrhages, new vessel growth, and so on — and is staged from mild NPDR to PDR. Diabetic Macular Edema (DME) is a specific complication in which fluid leaks from damaged vessels and accumulates within the central retina (the macula), causing blurred or distorted central vision. DME is the most common cause of vision loss in diabetic patients and can occur at any stage of retinopathy — even in mild NPDR. They often coexist and are both assessed at every retinal examination.
Is laser treatment for diabetic retinopathy painful?
Laser photocoagulation is performed as an outpatient procedure after dilating the pupil. Anaesthetic drops are used to numb the eye surface. During PRP (pan-retinal photocoagulation), patients may feel a mild stinging or pricking sensation with each laser pulse, and some describe a dim flash of light. The degree of discomfort varies between individuals — most patients tolerate it well, though a small minority find it uncomfortable. PRP is typically performed over one to three sessions, each lasting 15 to 20 minutes. Any discomfort is temporary, and the benefit — a dramatically reduced risk of blindness — far outweighs the mild procedural discomfort. Intravitreal injections for DME are similarly well-tolerated with topical anaesthesia.
Diabetic? Get Your Retina Checked Now
Annual retinal screening can prevent blindness. Dr. Jeenu Priya Tyagi offers comprehensive diabetic eye evaluation at Haripriya Eye Care Centre, Meerut.
Book a Retinal Exam →